Amylyx Pharmaceuticals (AMLX) EPS (Basic) (2021 - 2026)
Amylyx Pharmaceuticals' (AMLX) quarterly EPS (Basic) came in at -$0.82 in Q1 2026, down 96.33% year-on-year from -$22.39 in Q1 2025, and down 135.73% quarter-over-quarter from -$0.35 in Q4 2025.
Amylyx Pharmaceuticals (AMLX) EPS (Basic) (2021 - 2026) Analysis & Trends
Amylyx Pharmaceuticals' EPS (Basic) history runs 6 years deep, the most recent figure standing at -$0.82 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 96.33% year-over-year to -$0.82 in Q1 2026; TTM through Mar 2026 was -$1.81, a 0.61% increase from a year earlier, with the FY2025 full-year figure at -$1.53, up 56.31% from the prior year.
- EPS (Basic) slipped to -$0.82 in Q1 2026 per AMLX's latest filing, from -$0.35 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.37 in Q4 2024 and bottomed at -$1.75 in Q1 2024.
- The 5-year median for EPS (Basic) is -$0.46 (2025), against an average of -$0.52.
- Biggest YoY gain for EPS (Basic) was 833.27% in 2024; the steepest drop was 7525.45% in 2024.
- Year by year, EPS (Basic) stood at -$0.75 in 2022, then surged by 105.36% to $0.04 in 2023, then soared by 833.27% to $0.37 in 2024, then sank by 193.21% to -$0.35 in 2025, then plunged by 135.73% to -$0.82 in 2026.
- Per Business Quant, the three latest AMLX EPS (Basic) figures stand at -$0.82 (Q1 2026), -$0.35 (Q4 2025), and -$0.37 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 6.32 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.11 |
| 10 | Amylyx Pharmaceuticals | 1.94 Bn | 1.94 Bn | - | -0.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.82 |
| Dec 31, 2025 | -0.35 |
| Sep 30, 2025 | -0.37 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -0.42 |
| Dec 31, 2024 | 0.37 |
| Sep 30, 2024 | -1.07 |
| Jun 30, 2024 | -1.07 |
| Mar 31, 2024 | -1.75 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.31 |
| Jun 30, 2023 | 0.33 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | -0.75 |
| Sep 30, 2022 | -0.92 |
| Jun 30, 2022 | -0.93 |
| Mar 31, 2022 | -0.93 |
| Dec 31, 2021 | -4.30 |
| Sep 30, 2021 | -3.42 |
| Jun 30, 2021 | -3.41 |